This inventor holds 2 USPTO granted patents. Top assignees: Acf Chemiefarma N.v., Sandoz Gmbh. Active years: 1982-1983.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1982-1983
Title: Magda Marko: Innovator in Hormonal Research
Introduction
Magda Marko is a notable inventor based in Binningen, Switzerland. She has made significant contributions to the field of hormonal research, particularly in the development of methods to inhibit luteinizing hormone secretion. With a total of 2 patents, her work has implications for both medical and pharmaceutical applications.
Latest Patents
Magda Marko's latest patents include a method of inhibiting luteinizing hormone secretion using 6,7-benzomorphan derivatives. These compounds are characterized by their complex chemical structures, which include various substituents that enhance their analgesic properties. The innovative approach she has developed involves administering specific organic compounds that target hormone secretion effectively.
Career Highlights
Throughout her career, Magda has worked with prominent companies in the pharmaceutical industry, including ACF Chemiefarma N.V. and Sandoz GmbH. Her experience in these organizations has allowed her to refine her research and contribute to advancements in hormonal therapies.
Collaborations
Magda has collaborated with various professionals in her field, including her coworker Hendricus B. Welle. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Magda Marko's contributions to hormonal research and her innovative patents highlight her role as a leading inventor in her field. Her work continues to influence the development of new therapeutic methods.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile